Table 2.
Angiographic and procedural characteristics
| Characteristics | DM | P | No-DM | P | ||
|---|---|---|---|---|---|---|
| G2‑DES N = 1862 |
BP‑DES N = 421 |
G2‑DES N = 4232 |
BP‑DES N = 1151 |
|||
| Lesions involving LM | 46 (2.5) | 9 (2.1) | 0.688 | 81 (1.9) | 15 (1.3) | 0.165 |
| Lesions involving LAD | 1703 (91.5) | 377 (89.5) | 0.213 | 3929 (92.8) | 1050 (91.2) | 0.065 |
| Lesions involving LCX | 308 (16.5) | 56 (13.3) | 0.101 | 565 (13.4) | 163 (14.2) | 0.476 |
| Lesions involving RCA | 373 (20.0) | 94 (22.3) | 0.292 | 713 (16.8) | 183 (15.9) | 0.444 |
| Number of lesions treated | 1.4 ± 0.6 | 1.4 ± 0.6 | 0.664 | 1.3 ± 0.59 | 1.34 ± 0.60 | 0.013 |
| Number of stents | 1.8 ± 1.0 | 1.7 ± 0.9 | 0.177 | 1.75 ± 0.89 | 1.67 ± 0.88 | 0.391 |
| Number of target vessel | ||||||
| Single vessel | 386 (20.7) | 70 (16.6) | 0.057 | 1320 (31.2) | 340 (29.5) | 0.282 |
| Double vessel | 576 (30.9) | 143 (34.0) | 0.578 | 1316 (31.1) | 379 (32.9) | 0.236 |
| Triple vessel | 779 (41.8) | 185 (43.9) | 0.429 | 1349 (31.9) | 378 (32.8) | 0.534 |
| SYNTEX score | 11.7 ± 8.0 | 11.9 ± 8.2 | 0.684 | 10.9 ± 7.7 | 11.0 ± 7.8 | 0.329 |
| Normal origin of coronary artery | 1774 (95.3) | 403 (95.7) | 0.692 | 4051 (95.7) | 1102 (95.7) | 0.977 |
| Right distribution of coronary artery | 1633 (87.7) | 382 (90.7) | 0.081 | 3747 (88.5) | 1019 (88.5) | 0.994 |
| Transradial approach | 1664 (89.4) | 375 (89.1) | 0.861 | 3813 (90.1) | 1011 (87.8) | 0.026 |
| Pulling out sheath directly | 1408 (75.6) | 328 (77.9) | 0.320 | 3277 (77.4) | 904 (78.5) | 0.424 |
| IVUS application | 97 (5.2) | 16 (3.8) | 0.229 | 218 (5.2) | 58 (5.0) | 0.878 |
| IABP application | 25 (1.3) | 5 (1.2) | 0.801 | 40 (0.9) | 12 (1.0) | 0.765 |
| TIMI flow before PCI | ||||||
| 0 | 321 (17.2) | 71 (16.9) | 0.995 | 678 (16.0) | 235 (20.4) | < 0.001 |
| 1 | 61 (3.3) | 20 (4.8) | 0.626 | 123 (2.9) | 35 (3.0) | 0.811 |
| 2 | 221 (11.9) | 36 (8.6) | 0.290 | 483 (11.4) | 125 (10.9) | 0.599 |
| 3 | 1259 (67.6) | 294 (69.8) | 0.247 | 2948 (69.7) | 756 (65.7) | 0.010 |
| TIMI flow after PCI | ||||||
| 0 | 21 (1.1) | 6 (1.4) | 0.593 | 41 (1.0) | 12 (1.0) | 0.822 |
| 1 | 3 (0.2) | 0 (0) | > 0.999 | 9 (0.2) | 3 (0.3) | 0.728 |
| 2 | 10 (0.5) | 4 (1.0) | 0.226 | 30 (0.7) | 11 (1.0) | 0.393 |
| 3 | 1828 (98.2) | 411 (97.6) | 0.754 | 4152 (98.1) | 1125 (97.7) | 0.425 |
| B2 or C lesions | 1430 (76.8) | 330 (78.4) | 0.484 | 3101 (73.3) | 885 (76.9) | 0.013 |
| severe calcification | 72 (3.9) | 13 (3.1) | 0.446 | 115 (2.7) | 29 (2.5) | 0.712 |
| CTO lesions | 143 (7.7) | 30 (7.1) | 0.698 | 267 (6.3) | 107 (9.3) | < 0.001 |
| Ostial lesions | 316 (17.0) | 66 (15.7) | 0.521 | 697 (16.5) | 178 (15.5) | 0.413 |
| Bifurcation lesions | 346 (18.6) | 77 (18.3) | 0.889 | 825 (19.5) | 239 (20.8) | 0.337 |
| Thrombosis | 67 (3.6) | 15 (3.6) | 0.972 | 173 (4.1) | 50 (4.3) | 0.699 |
DM diabetes mellitus, BP-DES biodegradable polymer drug-eluting stents, G2-DES second generation drug-eluting stents, LM left main, LAD left anterior descending, LCX left circumflex, RCA right coronary artery, SYNTEX synergy between percutaneous coronary interventions with TAXUS and cardiac surgery, IVUS intravascular ultrasound, IABP intra-aortic balloon pump, TIMI thrombolysis in myocardial infarction, PCI percutaneous coronary intervention, CTO chronic total occlusion